| 2008 JASN IMPACT FACTOR 7.505 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CLINICAL RESEARCH |





,||

* Servicio de Nefrología y Trasplante renal,
Laboratorio Experimental de Nefrología y Trasplante renal,
Unidad de Bioinformática,
Servicio Anatomía Patologica, Hospital Clinic, Institut dInvestigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universidad de Barcelona, and ¶ Laboratorio de Proteómica Consejo Superior de Investigaciones Científicas (CSIC)/Universidad Autonoma, Instituto de Investigaciones Biomedicas de Barcelona/CSIC-Institut dInvestigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain; and || Department of Nephrology, Charité Campus Mitte, Berlin, Germany
Correspondence: Dr. Luís F. Quintana, Servicio de Nefrología y Trasplante renal, Hospital Clinic, Villarroel 170, 08036 Barcelona, Spain. Phone and Fax: 34-3-2275444; E-mail: lfquinta{at}clinic.ub.es
Received for publication October 23, 2007. Accepted for publication August 27, 2008.
Despite optimal immunosuppressive therapy, more than 50% of kidney transplants fail because of chronic allograft dysfunction. A noninvasive means to diagnose chronic allograft dysfunction may allow earlier interventions that could improve graft half-life. In this proof-of-concept study, we used mass spectrometry to analyze differences in the urinary polypeptide patterns of 32 patients with chronic allograft dysfunction (14 with pure interstitial fibrosis and tubular atrophy and 18 with chronic active antibody-mediated rejection) and 18 control subjects (eight stable recipients and 10 healthy control subjects). Unsupervised hierarchical clustering showed good segregation of samples in groups corresponding mainly to the four biomedical conditions. Moreover, the composition of the proteome of the pure interstitial fibrosis and tubular atrophy group differed from that of the chronic active antibody-mediated rejection group, and an independent validation set confirmed these results. The 14 protein ions that best discriminated between these two groups correctly identified 100% of the patients with pure interstitial fibrosis and tubular atrophy and 100% of the patients with chronic active antibody-mediated rejection. In summary, this study establishes a pattern for two histologic lesions associated with distinct graft outcomes and constitutes a first step to designing a specific, noninvasive diagnostic tool for chronic allograft dysfunction.
Related Article
J. Am. Soc. Nephrol. 2009 20: 236-238.
This article has been cited by other articles:
![]() |
L. F. Quintana, J. M. Campistol, M. P. Alcolea, E. Banon-Maneus, A. Sol-Gonzalez, and P. R. Cutillas Application of Label-free Quantitative Peptidomics for the Identification of Urinary Biomarkers of Kidney Chronic Allograft Dysfunction Mol. Cell. Proteomics, July 1, 2009; 8(7): 1658 - 1673. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Nickerson and P. S. Heeger Proteomic Portrayal of Transplant Pathologies J. Am. Soc. Nephrol., February 1, 2009; 20(2): 236 - 238. [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673